Filament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel Disease
31 janv. 2018 08h00 HE
|
Filament BioSolutions, Inc.
NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, Inc., a company focused on the development and commercialization of clinical nutrition therapeutics announced a collaboration with...
Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease
31 janv. 2018 07h30 HE
|
Biotagenics Inc.
TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biotagenics Inc., a microbiome-based platform company developing novel therapeutics and diagnostics is the industrial collaborator on a $9.1 million CAD...
IBD Releases Sixth Annual Best Online Brokers Survey
29 janv. 2018 09h00 HE
|
Investor's Business Daily
LOS ANGELES, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced the results of its sixth annual investor survey of...
Lyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel Disease
17 janv. 2018 08h00 HE
|
Lyfebulb
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Lyfebulb, a chronic disease-focused, patient-empowerment platform that connects patients, industry and investors to support user-driven innovation, is...
Qu Biologics invited to present research data at inaugural Crohn’s and Colitis Congress
19 déc. 2017 12h45 HE
|
Qu Biologics
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Economic Optimism Marks One Year in Positive Territory, the Longest Stretch in More Than a Decade, and Continues to Climb According to September IBD/TIPP Poll
07 sept. 2017 10h00 HE
|
Investor's Business Daily
LOS ANGELES, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The IBD/TIPP Economic Optimism Index, a leading national poll on consumer confidence, showed positive momentum this month, climbing another 1.7...
CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research
01 août 2017 08h00 HE
|
Crown Bioscience
SANTA CLARA, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development...
Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis
30 mai 2017 08h00 HE
|
Atlantic Healthcare plc
CAMBRIDGE, U.K., May 30, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication
22 mai 2017 08h00 HE
|
Atlantic Healthcare plc
CAMBRIDGE, U.K., May 22, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...
Whipsaw Celebrated at Fast Company Innovation by Design Awards
15 sept. 2016 06h40 HE
|
Whipsaw Inc
SAN JOSE, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Whipsaw Inc, the Silicon Valley-based Industrial Design and Engineering firm that creates innovative products for companies around the globe,...